As the PD-L1/PD-1 pathway has been recognized as a molecular checkpoint in immune evasion in various cancers (18–22), we next examined the effect of IL-21 on Treg generation from CD4+ T cells in the presence of PD-L1. The gene discussed is IL21; the disease is cancer.